ClinicalTrials.gov record
Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy
ClinicalTrials.gov ID: NCT01200589
Public ClinicalTrials.gov record NCT01200589. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III Randomized, Open Label Study of Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy
Study identification
- NCT ID
- NCT01200589
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 438 participants
Conditions and interventions
Conditions
Interventions
- Ofatumumab Biological
- Rituximab Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 10, 2010
- Primary completion
- Dec 18, 2016
- Completion
- Dec 18, 2016
- Last update posted
- May 15, 2018
2010 – 2016
United States locations
- U.S. sites
- 70
- U.S. states
- 31
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Anchorage | Alaska | 99508 | — |
| Novartis Investigative Site | Gilbert | Arizona | 85234 | — |
| Novartis Investigative Site | Hot Springs | Arkansas | 71913 | — |
| Novartis Investigative Site | Greenbrae | California | 94904 | — |
| Novartis Investigative Site | Monterey | California | 93940 | — |
| Novartis Investigative Site | Pleasant Hill | California | 94523 | — |
| Novartis Investigative Site | Rancho Mirage | California | 92270 | — |
| Novartis Investigative Site | Salinas | California | 93901 | — |
| Novartis Investigative Site | San Diego | California | 92123 | — |
| Novartis Investigative Site | San Pablo | California | 94806 | — |
| Novartis Investigative Site | Santa Monica | California | 90403 | — |
| Novartis Investigative Site | New Milford | Connecticut | 06776 | — |
| Novartis Investigative Site | Torrington | Connecticut | 06790 | — |
| Novartis Investigative Site | Lakeland | Florida | 33805 | — |
| Novartis Investigative Site | Orlando | Florida | 32806 | — |
| Novartis Investigative Site | Pembroke Pines | Florida | 33028 | — |
| Novartis Investigative Site | Port Saint Lucie | Florida | 34952 | — |
| Novartis Investigative Site | West Palm Beach | Florida | 33401 | — |
| Novartis Investigative Site | Macon | Georgia | 31201-8300 | — |
| Novartis Investigative Site | Marietta | Georgia | 30060 | — |
| Novartis Investigative Site | Evanston | Illinois | 60201 | — |
| Novartis Investigative Site | Peoria | Illinois | 61615 | — |
| Novartis Investigative Site | Quincy | Illinois | 62301 | — |
| Novartis Investigative Site | Skokie | Illinois | 60076 | — |
| Novartis Investigative Site | Anderson | Indiana | 46016 | — |
| Novartis Investigative Site | Indianapolis | Indiana | 46237 | — |
| Novartis Investigative Site | Ames | Iowa | 50010 | — |
| Novartis Investigative Site | Mount Sterling | Kentucky | 40353 | — |
| Novartis Investigative Site | Metairie | Louisiana | 70006 | — |
| Novartis Investigative Site | Shreveport | Louisiana | 71103 | — |
| Novartis Investigative Site | Waterville | Maine | 04901 | — |
| Novartis Investigative Site | Silver Spring | Maryland | 20910 | — |
| Novartis Investigative Site | Grand Rapids | Michigan | 49503 | — |
| Novartis Investigative Site | Kalamazoo | Michigan | 49007 | — |
| Novartis Investigative Site | Jackson | Mississippi | 39202 | — |
| Novartis Investigative Site | Columbia | Missouri | 65201 | — |
| Novartis Investigative Site | Kansas City | Missouri | 64111 | — |
| Novartis Investigative Site | Saint Joseph | Missouri | 64507 | — |
| Novartis Investigative Site | Springfield | Missouri | 65807 | — |
| Novartis Investigative Site | Bozeman | Montana | 59715 | — |
| Novartis Investigative Site | Lincoln | Nebraska | 68506 | — |
| Novartis Investigative Site | Lincoln | Nebraska | 68510 | — |
| Novartis Investigative Site | Albuquerque | New Mexico | 87110 | — |
| Novartis Investigative Site | Albuquerque | New Mexico | 87131 | — |
| Novartis Investigative Site | Lake Success | New York | 10042 | — |
| Novartis Investigative Site | Mount Kisco | New York | 10549 | — |
| Novartis Investigative Site | Greensboro | North Carolina | 27403 | — |
| Novartis Investigative Site | Bismarck | North Dakota | 58501 | — |
| Novartis Investigative Site | Canton | Ohio | 44708 | — |
| Novartis Investigative Site | Canton | Ohio | 44710 | — |
| Novartis Investigative Site | Portland | Oregon | 97213 | — |
| Novartis Investigative Site | Danville | Pennsylvania | 17822 | — |
| Novartis Investigative Site | Ephrata | Pennsylvania | 17522 | — |
| Novartis Investigative Site | Lancaster | Pennsylvania | 17605 | — |
| Novartis Investigative Site | Willow Grove | Pennsylvania | 19090 | — |
| Novartis Investigative Site | Chattanooga | Tennessee | 37404 | — |
| Novartis Investigative Site | Germantown | Tennessee | 38138 | — |
| Novartis Investigative Site | Knoxville | Tennessee | 37916 | — |
| Novartis Investigative Site | Fort Sam Houston | Texas | 78234 | — |
| Novartis Investigative Site | Houston | Texas | 77030 | — |
| Novartis Investigative Site | Ogden | Utah | 84403 | — |
| Novartis Investigative Site | Salt Lake City | Utah | 84106 | — |
| Novartis Investigative Site | Fredericksburg | Virginia | 22408 | — |
| Novartis Investigative Site | Kennewick | Washington | 99336 | — |
| Novartis Investigative Site | Kirkland | Washington | 98034 | — |
| Novartis Investigative Site | Mount Vernon | Washington | 98273 | — |
| Novartis Investigative Site | Seattle | Washington | 98109 | — |
| Novartis Investigative Site | Seattle | Washington | 98112 | — |
| Novartis Investigative Site | Sequim | Washington | 98382 | — |
| Novartis Investigative Site | Spokane | Washington | 99208 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 85 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01200589, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 15, 2018 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01200589 live on ClinicalTrials.gov.